NCT03613324

Brief Summary

Prevalence rates of bladder outlet obstruction (BOO) and detrusor underactivity (DU) and their related clinical and urodynamic findings in women with ≥ pelvic organ prolapse quantification stage II cystocele are important for clinical consultation. Thus, the aim of this study was to elucidate the above findings and between-group associations.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
455

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2011

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2011

Completed
6.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2017

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2018

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

July 18, 2018

Completed
16 days until next milestone

First Posted

Study publicly available on registry

August 3, 2018

Completed
Last Updated

August 3, 2018

Status Verified

July 1, 2018

Enrollment Period

6.9 years

First QC Date

July 18, 2018

Last Update Submit

August 1, 2018

Conditions

Keywords

CystoceleBladder outlet obstructionDetrusor underactivityUrodynamic study

Outcome Measures

Primary Outcomes (2)

  • BOO

    Bladder outlet obstruction: Qmax was \<12 mL/s and PdetQmax was ≥25 cmH2O with sustained detrusor contraction during voiding cystometry.

    November 2011 to January 2017

  • DU

    Detrusor underactivity: \<12 mL/s and PdetQmax was \<10 cmH2O

    November 2011 to January 2017

Study Arms (3)

Bladder outlet obstruction (BOO)

Between November 2011 and January 2017, medical records of all women with ≥stage II cystocele who underwent 20 min pad testing and urodynamic studies in a medical center were reviewed. Woman were defined as having BOO when Qmax was \<12 mL/s and PdetQmax was ≥25 cmH2O with sustained detrusor contraction during voiding cystometry.

Diagnostic Test: Pad test

Detrusor underactivity (DU)

Between November 2011 and January 2017, medical records of all women with ≥stage II cystocele who underwent 20 min pad testing and urodynamic studies in a medical center were reviewed. Woman were defined as having DU when Qmax was \<12 mL/s and PdetQmax was \<10 cmH2O during voiding cystometry.

Diagnostic Test: Pad test

ND BOO/DU

Between November 2011 and January 2017, medical records of all women with ≥stage II cystocele who underwent 20 min pad testing and urodynamic studies in a medical center were reviewed. This group revealed no demonstrated bladder outlet obstruction nor detrusor underactivity.

Diagnostic Test: Pad test

Interventions

Pad testDIAGNOSTIC_TEST

20-minutes pad test and urodynamic study including uroflowmetry, filling cystometry and voiding cystometry.

Also known as: Urodynamic study
Bladder outlet obstruction (BOO)Detrusor underactivity (DU)ND BOO/DU

Eligibility Criteria

Age20 Years+
Sexfemale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Women with more than stage II cystocele

You may qualify if:

  • Age \> 20y/o
  • Cystocele \> stage II
  • Complete pad test and urodynamic study

You may not qualify if:

  • Pregnancy
  • Urinary tract infection
  • Had received pelvic reconstruction surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Urinary Bladder Neck ObstructionCystoceleUrinary Bladder, Underactive

Condition Hierarchy (Ancestors)

Urethral ObstructionUrethral DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesUrinary Bladder DiseasesMale Urogenital DiseasesPelvic Organ ProlapseProlapsePathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsLower Urinary Tract SymptomsUrological ManifestationsSigns and Symptoms

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 18, 2018

First Posted

August 3, 2018

Study Start

January 1, 2011

Primary Completion

November 30, 2017

Study Completion

May 31, 2018

Last Updated

August 3, 2018

Record last verified: 2018-07

Data Sharing

IPD Sharing
Will not share

No plan to share IPD